These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30132166)

  • 21. miR-192 suppresses leptomeningeal dissemination of medulloblastoma by modulating cell proliferation and anchoring through the regulation of DHFR, integrins, and CD47.
    Yang SY; Choi SA; Lee JY; Park AK; Wang KC; Phi JH; Koh EJ; Park WY; Park SH; Hwang DW; Jung HW; Kim SK
    Oncotarget; 2015 Dec; 6(41):43712-30. PubMed ID: 26506238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PI-3K Inhibitors Preferentially Target CD15+ Cancer Stem Cell Population in SHH Driven Medulloblastoma.
    Singh AR; Joshi S; Zulcic M; Alcaraz M; Garlich JR; Morales GA; Cho YJ; Bao L; Levy ML; Newbury R; Malicki D; Messer K; Crawford J; Durden DL
    PLoS One; 2016; 11(3):e0150836. PubMed ID: 26938241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response of preclinical medulloblastoma models to combination therapy with 13-cis retinoic acid and suberoylanilide hydroxamic acid (SAHA).
    Spiller SE; Ditzler SH; Pullar BJ; Olson JM
    J Neurooncol; 2008 Apr; 87(2):133-41. PubMed ID: 18060600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of action and therapeutic efficacy of Aurora kinase B inhibition in MYC overexpressing medulloblastoma.
    Diaz RJ; Golbourn B; Faria C; Picard D; Shih D; Raynaud D; Leadly M; MacKenzie D; Bryant M; Bebenek M; Smith CA; Taylor MD; Huang A; Rutka JT
    Oncotarget; 2015 Feb; 6(5):3359-74. PubMed ID: 25739120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo variation in transferrin receptor expression on a human medulloblastoma cell line.
    Wen DY; Hall WA; Conrad J; Godal A; Flørenes VA; Fodstad O
    Neurosurgery; 1995 Jun; 36(6):1158-63; discussion 1163-4. PubMed ID: 7643997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RITA displays anti-tumor activity in medulloblastomas independent of TP53 status.
    Gottlieb A; Althoff K; Grunewald L; Thor T; Odersky A; Schulte M; Deubzer HE; Heukamp L; Eggert A; Schramm A; Schulte JH; Künkele A
    Oncotarget; 2017 Apr; 8(17):27882-27891. PubMed ID: 28427187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BET bromodomain protein inhibition is a therapeutic option for medulloblastoma.
    Henssen A; Thor T; Odersky A; Heukamp L; El-Hindy N; Beckers A; Speleman F; Althoff K; Schäfers S; Schramm A; Sure U; Fleischhack G; Eggert A; Schulte JH
    Oncotarget; 2013 Nov; 4(11):2080-95. PubMed ID: 24231268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Novel Combination Approach Targeting an Enhanced Protein Synthesis Pathway in MYC-driven (Group 3) Medulloblastoma.
    Chaturvedi NK; Kling MJ; Griggs CN; Kesherwani V; Shukla M; McIntyre EM; Ray S; Liu Y; McGuire TR; Sharp JG; Band H; Joshi SS; Coulter DW
    Mol Cancer Ther; 2020 Jun; 19(6):1351-1362. PubMed ID: 32371591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticancer activity of tolfenamic acid in medulloblastoma: a preclinical study.
    Eslin D; Lee C; Sankpal UT; Maliakal P; Sutphin RM; Abraham L; Basha R
    Tumour Biol; 2013 Oct; 34(5):2781-9. PubMed ID: 23686785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender effect in experimental models of human medulloblastoma: does the estrogen receptor β signaling play a role?
    Ciucci A; Meco D; De Stefano I; Travaglia D; Zannoni GF; Scambia G; Riccardi R; Saran A; Mancuso M; Gallo D
    PLoS One; 2014; 9(7):e101623. PubMed ID: 25000562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma.
    Rusert JM; Juarez EF; Brabetz S; Jensen J; Garancher A; Chau LQ; Tacheva-Grigorova SK; Wahab S; Udaka YT; Finlay D; Seker-Cin H; Reardon B; Gröbner S; Serrano J; Ecker J; Qi L; Kogiso M; Du Y; Baxter PA; Henderson JJ; Berens ME; Vuori K; Milde T; Cho YJ; Li XN; Olson JM; Reyes I; Snuderl M; Wong TC; Dimmock DP; Nahas SA; Malicki D; Crawford JR; Levy ML; Van Allen EM; Pfister SM; Tamayo P; Kool M; Mesirov JP; Wechsler-Reya RJ
    Cancer Res; 2020 Dec; 80(23):5393-5407. PubMed ID: 33046443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional evaluation of therapeutic response for a mouse model of medulloblastoma.
    Samano AK; Ohshima-Hosoyama S; Whitney TG; Prajapati SI; Kilcoyne A; Taniguchi E; Morgan WW; Nelon LD; Lin AL; Togao O; Jung I; Rubin BP; Nowak BM; Duong TQ; Keller C
    Transgenic Res; 2010 Oct; 19(5):829-40. PubMed ID: 20107895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cells.
    von Bueren AO; Shalaby T; Rajtarova J; Stearns D; Eberhart CG; Helson L; Arcaro A; Grotzer MA
    BMC Cancer; 2007 Jan; 7():19. PubMed ID: 17254356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity.
    Vassal G; Boland I; Terrier-Lacombe MJ; Watson AJ; Margison GP; Vénuat AM; Morizet J; Parker F; Lacroix C; Lellouch-Tubiana A; Pierre-Kahn A; Poullain MG; Gouyette A
    Clin Cancer Res; 1998 Feb; 4(2):463-8. PubMed ID: 9516937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo.
    Lee SJ; Krauthauser C; Maduskuie V; Fawcett PT; Olson JM; Rajasekaran SA
    BMC Cancer; 2011 Apr; 11():144. PubMed ID: 21501498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triptolide inhibits the proliferation and migration of medulloblastoma Daoy cells by upregulation of microRNA-138.
    Zhang H; Li H; Liu Z; Ge A; Guo E; Liu S; Chen Z
    J Cell Biochem; 2018 Dec; 119(12):9866-9877. PubMed ID: 30156009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic targets for medulloblastoma.
    Wlodarski PK; Jozwiak J
    Expert Opin Ther Targets; 2008 Apr; 12(4):449-61. PubMed ID: 18348681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medulloblastoma cell-substrate interaction in vitro.
    Wikstrand CJ; Friedman HS; Bigner DD
    Invasion Metastasis; 1991; 11(6):310-24. PubMed ID: 1822845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antineoplastic effects of gallium nitrate on human medulloblastoma in vivo.
    Whelan HT; Schmidt MH; Anderson GS; Chan BK; Hunter K; Kubacki D; Segura AD; Chitambar CR
    Pediatr Neurol; 1992; 8(5):323-7. PubMed ID: 1418174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of new retinoids in the prevention of mammary cancers and correlations with short-term biomarkers.
    Grubbs CJ; Lubet RA; Atigadda VR; Christov K; Deshpande AM; Tirmal V; Xia G; Bland KI; Eto I; Brouillette WJ; Muccio DD
    Carcinogenesis; 2006 Jun; 27(6):1232-9. PubMed ID: 16344269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.